Cellectar Biosciences (NASDAQ:CLRB – Get Free Report) will likely be issuing its quarterly earnings data before the market ...
The company received a letter of acceptance (LoA) from Bihar Medical Services and Infrastructure Corporation Limited for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback